Hernes E - Search Results

1

Fatigue in hormone-naïve prostate cancer patients treated with radical prostatectomy or definitive radiotherapy.

Kyrdalen AE, Dahl AA, Hernes E, Cvancarova M, Fosså SD. Kyrdalen AE, et al. Among authors: hernes e. Prostate Cancer Prostatic Dis. 2010 Jun;13(2):144-50. doi: 10.1038/pcan.2009.61. Epub 2010 Jan 26. Prostate Cancer Prostatic Dis. 2010. PMID: 20101260

2

Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.

Hernes EH, Fosså SD, Vaage S, Ogreid P, Heilo A, Paus E. Hernes EH, et al. Br J Cancer. 1997;76(1):93-9. doi: 10.1038/bjc.1997.342. Br J Cancer. 1997. PMID: 9218739 Free PMC article. Clinical Trial.

3

[Prostate-specific antigen in the follow-up of conservatively treated prostatic cancer].

Otnes B, Hernes E, Fosså SD. Otnes B, et al. Among authors: hernes e. Tidsskr Nor Laegeforen. 1998 Sep 20;118(22):3401-5. Tidsskr Nor Laegeforen. 1998. PMID: 9800488 Norwegian.

4

Hormone-resistant prostate cancer with symptomatic pelvic tumours: patient survival and prognostic factors.

Hernes EH, Linja M, Fosså SD, Visakorpi T, Berner A, Winderen M, Koivisto PA. Hernes EH, et al. BJU Int. 2000 Aug;86(3):240-7. doi: 10.1046/j.1464-410x.2000.00767.x. BJU Int. 2000. PMID: 10930923

5

Androgen-independent prostate cancer--the clinical problem of a growing pelvic tumour.

Hernes E, Fosså SD, Skovlund E. Hernes E, et al. Acta Oncol. 2003;42(7):749-55. doi: 10.1080/02841860310014624. Acta Oncol. 2003. PMID: 14690161

6

Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence.

Hernes E, Fosså SD, Berner A, Otnes B, Nesland JM. Hernes E, et al. Br J Cancer. 2004 Jan 26;90(2):449-54. doi: 10.1038/sj.bjc.6601536. Br J Cancer. 2004. PMID: 14735192 Free PMC article.

7

NY-ESO-1 protein expression and humoral immune responses in prostate cancer.

Fosså A, Berner A, Fosså SD, Hernes E, Gaudernack G, Smeland EB. Fosså A, et al. Among authors: hernes e. Prostate. 2004 Jun 1;59(4):440-7. doi: 10.1002/pros.20025. Prostate. 2004. PMID: 15065093

8

High prostate cancer mortality in Norway: influence of Cancer Registry information?

Hernes E, Harvei S, Glattre E, Gjertsen F, Fosså SD. Hernes E, et al. APMIS. 2005 Jul-Aug;113(7-8):542-9. doi: 10.1111/j.1600-0463.2005.apm_245.x. APMIS. 2005. PMID: 16086825

9

[Treatment of hormone-resistant prostate cancer].

Lilleby W, Hernes E, Waehre H, Raabe N, Fosså SD. Lilleby W, et al. Among authors: hernes e. Tidsskr Nor Laegeforen. 2006 Nov 2;126(21):2798-801. Tidsskr Nor Laegeforen. 2006. PMID: 17086220 Free article. Review. Norwegian.

10

High prostate cancer mortality in Norway evaluated by automated classification of medical entities.

Hernes E, Johansson LA, Fosså SD, Pedersen AG, Glattre E. Hernes E, et al. Eur J Cancer Prev. 2008 Aug;17(4):331-5. doi: 10.1097/CEJ.0b013e3282f5220d. Eur J Cancer Prev. 2008. PMID: 18562957

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters